Kai Breuhahn
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Hepatology top 1%
Papers in
- Cell Biology 39
- Hippo pathway signaling and YAP/TAZ 23
- Microtubule and mitosis dynamics 8
-
- Cancer, Hypoxia, and Metabolism 11
- Co-authors
- Peter SchirmacherThomas LongerichStephan SingerFederico PinnaMichael KernManfred BlessingAmrit MannMichaela Bissinger
- Journals
- Hepatology (16 papers)Cancer Research (8 papers)Oncogene (5 papers)PLoS ONE (5 papers)International Journal of Cancer (4 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Kai Breuhahn
125 papers receiving 5.1k citations
Peers
Comparison fields: 5 of 133
- Cancer Research 1.4k
- Hepatology 540
- Molecular Biology 3.1k
- Cell Biology 685
- Oncology 1.0k
Countries citing papers authored by Kai Breuhahn
This map shows the geographic impact of Kai Breuhahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Breuhahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Breuhahn more than expected).
Fields of papers citing papers by Kai Breuhahn
This network shows the impact of papers produced by Kai Breuhahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Breuhahn. The network helps show where Kai Breuhahn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kai Breuhahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 21 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 9 | |
| 4 | 2020 | 37 | |
| 5 | 2019 | 31 | |
| 6 | 2017 | 53 | |
| 7 | 2016 | 13 | |
| 8 | 2016 | 29 | |
| 9 | 2014 | 27 | |
| 10 | 2012 | 23 | |
| 11 | 2012 | 125 | |
| 12 | 2012 | 49 | |
| 13 | 2009 | 83 | |
| 14 | 2007 | 123 | |
| 15 | 2007 | 2 | |
| 16 | 2006 | 21 | |
| 17 | 2006 | 319 | |
| 18 | 2005 | 20 | |
| 19 | 2005 | 120 | |
| 20 | 1997 | 18 |
About Kai Breuhahn
Kai Breuhahn is a scholar working on Cell Biology, Cancer Research, Hepatology, Molecular Biology and Biochemistry, having authored 128 papers that have together received 5.2k indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (23 papers), Ubiquitin and proteasome pathways (19 papers), Cancer-related Molecular Pathways (17 papers), RNA modifications and cancer (15 papers), Cancer, Hypoxia, and Metabolism (11 papers), Wnt/β-catenin signaling in development and cancer (10 papers), Liver physiology and pathology (9 papers) and Microtubule and mitosis dynamics (8 papers). The work is most often cited by research in Cancer Research (1.4k citations), Hepatology (540 citations), Molecular Biology (3.1k citations), Cell Biology (685 citations) and Oncology (1.0k citations). Kai Breuhahn has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Peter Schirmacher, Thomas Longerich, Stephan Singer, Federico Pinna, Michael Kern, Manfred Blessing, Amrit Mann, Michaela Bissinger, Peter Angel and Volker Ehemann. Their work appears in journals such as Hepatology, Cancer Research, Oncogene, PLoS ONE and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.